Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
Aidan M. Kirkham, Adrian Bailey, Risa Shorr, Manoj M. Lalu, Dean Fergusson, David Allan
Topics & Concepts
MedicineClinical endpointRandomized controlled trialMeta-analysisOdds ratioConfidence intervalMesenchymal stem cellAdverse effectRelative riskInternal medicineClinical trialPandemicDiseaseIntensive care medicineOncologyCoronavirus disease 2019 (COVID-19)PathologyInfectious disease (medical specialty)Mesenchymal stem cell researchCOVID-19 Clinical Research StudiesDermatological and COVID-19 studies